baber/WOPTO huggingface dataset:
Patent AU-2019282300-A1 (AU)
Title: Method for determining a flow speed of a fluid flowing through an implanted, vascular assistance system and implantable, vascular assistance system
Inventor: SCHLEBUSCH THOMAS ALEXANDER
IPC: A61M60/226
Filed: 2019-06-06
Abstract: The invention relates to a method for determining at least one flow speed or a fluid volume flow rate (5) of a fluid flowing through an implanted, vascular assistance system (1), comprising the following steps: a) carrying out a pulsed Doppler measurement by means of an ultrasonic sensor (2) of the assistance system (1), b) evaluating a measurement result from step a), which has a possible ambiguity, c) providing at least one operating parameter of a flow machine (3) of the assistance system (1), d) ascertaining at least the flow speed or the fluid volume flow rate (5) using the measurement result evaluated in step b), wherein the possible ambiguity of the measurement result is corrected using the operating parameter.
Patent AU-2019287661-A1 (AU)
Title: Apparatus and method for detection of physiological events
Inventor: AU YU KAN
IPC: A61B5/11
Filed: 2019-06-14
Abstract: A method includes receiving motion data from at least one sensor of a wearable device worn by a user. The method further includes receiving audio data from at least one sensor of the wearable device, the audio data representative of sounds emanating from the user's respiratory system. The method further includes comparing the motion data to a motion data criteria. The method further includes comparing the audio data an audio data criteria. The method further includes determining, based on the comparison of the motion data to the motion data criteria and the comparison of the audio data to the audio data criteria, whether the user has coughed.
Patent AU-2019307959-A1 (AU)
Title: FcRn antibody compositions
Inventor: ZHANG ZHONGLI
IPC: C07K1/26
Filed: 2019-07-19
Abstract: This disclosure pertains to compositions comprising an anti-FcRn antibody, M281. The compositions include the full, intact antibody and size variants thereof that not include two antibody heavy chains and to antibody light chains. Thus, a M281 pharmaceutical composition can include: an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO:2 and a light chain comprising the amino acid sequence of SEQ ID NO:1, wherein the composition comprises a major protein component having a molecular weight of 140,000 - 145,000 Da and a minor protein component of molecular weight 118,000 - 120,000 Da.
Patent AU-2019308173-A1 (AU)
Title: Inferred maximum temperature monitoring for irrigated ablation therapy
Inventor: CURLEY MICHAEL G
IPC: A61B18/12
Filed: 2019-07-12
Abstract: Methods and systems utilizing inferred maximum temperature monitoring for irrigated ablation therapy are described herein. In one embodiment, a method for ablating tissue includes positioning an elongate body proximate to tissue, where the elongate body includes an ablation element and at least one temperature sensor coupled thereto. The method can include simultaneously delivering ablative energy to the tissue through the ablation element and liquid through the elongate body. The method can further include pausing delivery of ablative energy and liquid, as well as sensing a temperature of the ablation element while delivery of ablative energy and liquid is paused. The method can further include any of terminating delivery of ablative energy and liquid and resuming delivery of ablative energy and liquid based on a comparison of the sensed temperature to a reference temperature.
Patent AU-2019324127-A1 (AU)
Title: Applications of known and novel cannabinoids
Inventor: BERKOWITZ BARRY A
IPC: C07C37/00
Filed: 2019-08-20
Abstract: The use of a medicament as a single agent, binary agent, or other combination comprising of substantially pure novel cannabinoids 1 and 2, optionally admixed with one or more known and novel cannabinoids and other known naturally occurring and synthetic tetracyclic 2A and tricyclic 1A cannabinoids for the prevention, treatment or cure of inflammatory mediated diseases or inflammatory mediated pathological conditions, anorexia, arthritis, cancer, pain, glaucoma, migraine, persistent muscle spasms, seizures (epileptic seizures), severe nausea, PTSD, autism spectrum disorder, drug abuse, insomnia, or any other chronic or persistent medical symptom.
Patent AU-2019355115-A1 (AU)
Title: Anti-CD79 antibodies and their uses
Inventor: LARRICK JAMES
IPC: C07K19/00
Filed: 2019-10-03
Abstract: The present disclosure provides humanized and affinity matured antibodies (mAbs) and fragments thereof that specifically bind to CD79 with high affinity. The anti-CD79 mAbs and fragments thereof can be used to treat antibody-associated conditions, including autoimmune diseases, allergies, transplant rejection, or immune-mediated rejection of a therapeutics optionally in combination with an additional therapeutic agent. Furthermore, the anti-CD79 mAbs and fragments thereof can be used for diagnostic purposes, including to detect CD79 cells in biological samples and to diagnose B-cell associated disorders.
Patent AU-2019355433-A1 (AU)
Title: Methods and compositions for modulation of tau proteins
Inventor: RILEY BRIGIT E
IPC: C12N15/864
Filed: 2019-10-02
Abstract: The present disclosure is in the field of diagnostics and therapeutics for Alzheimer's Disease.
Patent AU-2019362576-A1 (AU)
Title: Flavagline derivatives for inhibition of KRAS oncogene activation
Inventor: RAJALINGAM KRISHNARAJ
IPC: A61K31/343
Filed: 2019-10-15
Abstract: The present invention relates to inhibitors of KRAS oncogene activation, which are flavagline derivatives with the ability to target prohibitin to inhibit KRAS activation. The flavagline derivatives according to the invention have the general formula (I) in which R1 is -HO, -COO, -C(NH)O, -CO(NH)N-(CH
Patent AU-2019373462-A1 (AU)
Title: Self-advancing endoscopic probe and system comprising same
Inventor: SWITZER ANTHONY
IPC: A61B1/005
Filed: 2019-10-31
Abstract: Embodiments generally relate to propulsion devices, systems, or components thereof, for progressing instruments along passages, as well as associated methods of manufacture. For example, the instruments may include tools, sensors, probes and/or monitoring equipment for medical use (such as endoscopy) or industrial use (such as mining). The described embodiments may also be suitable for applications in other fields to progress an instrument along a passage. Some embodiments relate to an endoscope comprising or configured to receive a propulsion tube configured to assist in progressing the endoscope along a passage.
Patent AU-2019384150-A1 (AU)
Title: Hard hat lamp attachment system
Inventor: HYMA STEVEN W
IPC: A42B3/04
Filed: 2019-11-20
Abstract: A hard hat with symmetric front and back mounting ridges to support a headlamp is described. The hard hat provides mounting ridges to receive insertion slots of a rigid mounting bracket that fit around the ridges. The rigid mounting bracket includes channels to loop a strap through the channels and support a lamp on the bracket. The strap may include a hook and loop fastener system to enable attachment of a variety of lamps to the rigid support bracket. In this way, the hard hat can support a wide variety of headlamps attached to the rigid mounting bracket without destructive alterations to the hard hat. Clips may be added to the rigid mounting bracket to secure or lock the bracket in place during operation and prevent accidental knocks or jarring of the headlamp.
Patent AU-2019397828-A1 (AU)
Title: Device and method for transmitting maritime distress signal
Inventor: HWANG CHEONG HO
IPC: G08B21/02
Filed: 2019-11-22
Abstract: The present invention relates to a device for transmitting a maritime distress signal, whereby a distress signal from a person in distress at sea who is wearing a life jacket, as well as precise GPS-based location information can be transmitted in the form of audible sound so as to verify the state of distress to an arbitrary rescue site, thus enabling the person to be rescued. The device comprises: a holder-cradle coupled by a clip to a life jacket of a person in distress; and a main body unit which is coupled to the holder-cradle and transmits a rescue signal to an arbitrary receiving unit in a preset frequency range.
Patent AU-2019404617-A1 (AU)
Title: Methods and products for converting carbon dioxide to one or more small organic compounds
Inventor: JONES BRYN
IPC: B01J19/08
Filed: 2019-12-23
Abstract: The present disclosure relates to methods, systems and products for converting carbon dioxide to one or more small organic compounds. In certain embodiments, the present disclosure provides a method of converting CO
Patent AU-2019408277-A1 (AU)
Title: Dynamic building-integrated photovoltaics (DBIPV) using solar trees and solar sails and the like
Inventor: PAULUS ANTOINE MARCEL
IPC: H02S20/30
Filed: 2019-12-20
Abstract: An apparatus for converting solar energy to electrical energy comprises at least a central trunk or stem, preferably extending from a base, wherein the base can be attached to a stationary structure like a wall or a house or a garage or a bridge or wherein the base can be part of a mobile device having wheels and at least one or exactly one branch and preferably multiple branches connected to the central trunk or stem, wherein at least or exactly a first branch comprises one or more photovoltaic panels. Additionally, or alternatively comprises a second branch one or more photovoltaic panels. Each of the photovoltaic panels of the first branch preferably comprises one or more sheets of photovoltaic material and preferably one or more anchors for attaching the sheets of photovoltaic material to the first branch.
Patent AU-2019437315-A1 (AU)
Title: Long-acting fatty acid-binding GnRH derivative and pharmaceutical composition comprising same
Inventor: JIN DONG KYU
IPC: A61K47/69
Filed: 2019-03-26
Abstract: One aspect of the present disclosure relates to a novel long-acting fatty acid-binding gonadotrophin-releasing hormone (GnRH) derivative of GnRH and a pharmaceutical composition comprising same. The present disclosure is expected to greatly contribute to reducing the frequency or dosage of medicines in the treatment of sex hormone-dependent diseases through excellent bioavailability, prolonged blood half-life, and remarkably excellent sex hormone-dependent disease treatment effects of the fatty acid-binding GnRH derivative. In particular, it will be possible to overcome the disadvantages of existing GnRH sustained-release preparations that have side effects of residual tenderness and pain at an injection site.
Patent WO-2020227765-A1 (WO)
Title: Blood analysis devices, systems and methods
Inventor: VIGLIONE DEAN PETER
IPC: G01N21/31
Filed: 2020-05-12
Abstract: Methods and apparatus are provided for non-invasive blood analysis. A blood analysis device (10, 30) comprises a housing (24) for receiving a human or animal body part or a container of blood. The housing (24, 32) comprises at least one wave emitter (18) for emitting an emitted wave to target blood, and at least one wave sensor (26) for sensing a response wave after the emitted wave has interacted with the target blood. The at least one wave sensor is configured to output at least one sense signal allowing a frequency spectrum of the emitted wave to be constructed.
Patent WO-2021077154-A1 (WO)
Title: Method and apparatus for detecting changes in blood flow in the head of a subject
Inventor: VAN BOHEMEN SAMUEL JACOBUS
IPC: A61B5/026
Filed: 2020-08-27
Abstract: A method of detecting changes in blood flow in a head of a subject comprises measuring a value of a parameter of a cardiac bioelectrical signal at a scalp area of the subject relative to a reference cardiac bioelectrical signal. The method also includes comparing the value of the measured parameter with a predetermined value of the parameter to determine any change in blood flow in the head of the subject. The determined change can be used to detect changes in perfusion in the brain of a subject for example, as a result of anti-coagulation medication used to dissolve a clot in a blood vessel of the brain of a subject who has experienced ischaemic stroke.
Patent AU-2020200867-A1 (AU)
Title: Balloon dissector
Inventor: JONATHAN THOMAS
IPC: A61B17/00
Filed: 2020-02-06
Abstract: BALLOON DISSECTOR 
ABSTRACT 
A balloon dissector assembly (120) includes a balloon dissector having an elongate shaft 
(144), a handle (142) disposed on a proximal portion (144a) of the elongate shaft (144), and a 
dissection balloon (146) supported on a distal portion (144b) of the elongate shaft (144). The 
dissection balloon (146) includes a substantially cylindrical shape having a deflated condition in 
which the dissection balloon (146) includes a first diameter between the proximal and distal 
ends, an inflated condition in which the dissection balloon (146) includes a second diameter 
between the proximal and distal ends, and a plurality of intermediate conditions in which the 
balloon (146) transitions from the deflated condition to the inflated condition progressively from 
the proximal end to the distal end.
2/4 
146a 146 146b 
144 10t 134 
FIG. 2 
146a 140 
144 A"FIG. 3 
140 
146a "A" 
146 134 146b 
144 " 
FIG. 4 
146a 146b 
144 134 
FIG. 5 146
Patent AU-2020201052-A1 (AU)
Title: Mortice lock assembly with improved deadlatching
Inventor: TYZZER SIMON PAUL
IPC: E05B15/00
Filed: 2020-02-13
Abstract: This invention relates to a mortice lock assembly 1 including an inner hub 11 and an 
outer hub 14 which are each rotatable to retract a latchbolt 31. A lock mechanism is 
5 included to inhibit rotation of the inner hub 11 and outer hub 14, whilst a deadlatching 
mechanism is included to inhibit retraction of the latchbolt 31. A tolerance is provided 
between the lock mechanism and each of the inner hub 11 and outer hub 14, whilst a 
first lost motion is provided between the inner hub 11 or outer hub 14 and the 
deadlatching mechanism. The first lost motion allows for greater rotation of either the 
10 inner hub 11 or outer hub 14 than permitted by the tolerance.  
SPEC-1165071.docx
't/±0 
FIG. 4
Patent AU-2020202873-A1 (AU)
Title: A gaming system and a method of gaming
Inventor: LANGILLE JAMIE KEITH
IPC: G07F17/34
Filed: 2020-04-30
Abstract: Abstract A gaming system that is arranged to facilitate selection of one or more win lines by a player is described. The 5 gaming system comprises a weight allocator for allocating a weight to a wager, the allocated weight being dependent on a number of win lines selected by the player. The gaming system further comprises a prize allocator, and a trigger determiner arranged to determine a trigger 10 condition, the trigger condition being dependent at least in part on the allocated weight. The gaming system is arranged to allocate a prize to a player in response to determination of the trigger condition. 12320953_1 (GHMatters) P87047.AU.3 30/04/20
Patent AU-2020215613-A1 (AU)
Title: Immolative cell-penetrating complexes for nucleic acid delivery to the lung
Inventor: BLAKE TIM R
IPC: C12N11/00
Filed: 2020-01-31
Abstract: There are provided herein,
Patent AU-2020223379-A1 (AU)
Title: Vascularizing devices and methods for implanted diagnostics and therapeutics
Inventor: VEISEH OMID
IPC: A61L27/54
Filed: 2020-02-17
Abstract: The disclosure describes new devices and methods for vascularizing devices and methods for implanted diagnostics and therapeutics. The present disclosure provides, in certain embodiments, a device containing a degradable shell and a non-degradable core. In certain embodiments, the non-degradable core can include encapsulated therapeutic cells and/or biosensors, wherein the degradable shell serves as a scaffold for blood vessel growth, resulting in enhanced blood flow to the cells and/or biosensors.
Patent AU-2020223404-A1 (AU)
Title: Herbicidal compositions
Inventor: WILLETTS NIGEL JAMES
IPC: A01N43/50
Filed: 2020-01-30
Abstract: The present invention relates novel herbicidal combinations and their use in controlling plants or inhibiting plant growth. In particular, herbicidal combinations of the invention comprise at least one pyridazine derivative as defined herein, in combination with at least one futher herbicide that is an acetoclactase synthase (ALS) inhibitor.
Patent AU-2020226850-A1 (AU)
Title: System and method for voyage consumption optimization
Inventor: JHA SOMESH
IPC: G06Q10/08
Filed: 2020-01-29
Abstract: A system and method for predicting, forecasting and suggesting voyage plans for a vessel by considering design parameters, weather in sailing routes and a user's preference for best weather or best economy or fastest way to reach the destination. Voyage plans are optimized using the above parameters, and directions are continuously provided in the form of heading and speeds to be maintained by the vessel during the course of the voyage.
Patent AU-2020245709-A1 (AU)
Title: Process and system for generating hydrogen
Inventor: ANDERSON DUNCAN
IPC: C01B3/02
Filed: 2020-03-25
Abstract: Disclosed is a process and system for generating hydrogen from carbon dioxide. The process and system for generating a hydrogen gas stream from a carbon dioxide gas stream comprises converting a first waste carbon dioxide gas stream to an organic feedstock using an algal source in a photosynthesis step. The organic feedstock is then converted using an organism to the hydrogen gas stream and gaseous by-products in a biodecomposition step. The generated hydrogen gas may then be collected.
Patent AU-2020260550-A1 (AU)
Title: Device for catching urine sample
Inventor: HUGHES SAMANTHA
IPC: A61B10/00
Filed: 2020-10-30
Abstract: The invention provides a urine collection device for collecting a urine sample. The 
device comprises a seat portion supported by a seat base. The seat portion comprises a 
backrest and a saddle that projects from the seat portion. The saddle comprises an opening 
to a collection element that comprises a cup mount to locate a urine collection cup within the 
collection element.
1130 
1313 11 
1312 
1311 
1340 
2000 
1320 
1321 FIGURE 29a
Patent AU-2020264696-A1 (AU)
Title: Rechargeable battery cell
Inventor: ZINCK LAURENT
IPC: H01M10/052
Filed: 2020-04-07
Abstract: The invention relates to a rechargeable battery cell comprising a housing (1), at least one positive electrode (4), at least one negative electrode (5) and an electrolyte, which contains at least one conductive salt, which electrolyte is based on SO
Patent AU-2020277252-A1 (AU)
Title: System and method of auxiliary data access
Inventor: LANDRA CORINNE FRANCOISE PASCALE
IPC: G06F16/27
Filed: 2020-11-27
Abstract: A method of providing access to auxiliary data for a provider subsystem includes: storing 
offer data corresponding to an item, the offer data including (i) primary data, and (ii) auxiliary 
data defining an adjustment between the primary data and corresponding published data 
stored at an external repository; storing the offer data in an auxiliary repository; in response to 
an order request from a client subsystem: obtaining an order identifier corresponding to the 
offer data; and updating the auxiliary repository to store the order identifier in association 
with the offer data; in response to obtaining the order identifier, generating a reporting 
message for transmission to a provider subsystem, the reporting message containing the 
primary data and omitting the auxiliary data; and subsequent to generating the reporting 
message, retrieving the offer data from the auxiliary repository, and sending at least the 
auxiliary data to the provider subsystem.
7/7 
[Fig. 7] 
100 
124 
Publication 
Subsystem 
104 
Client 
subsystem I 120 
Intermediation Server 
404 408 508 
112 
128 
Order 
___ Subsystem 
108 
Provider Subsystem 
116 
Offer subsystem 
L -----------------
Downstream 136 
subsystem | Reporting 
..... ......----.- Subsystem
Patent AU-2020280543-A1 (AU)
Title: Anti-hepatitis B virus antibodies and use thereof
Inventor: LUO WENXIN
IPC: A61K39/42
Filed: 2020-05-22
Abstract: Antibodies (especially humanized antibodies) against the hepatitis B surface antigen (HBsAg), a nucleic acid molecule encoding same, a method for preparing same, and a pharmaceutical composition containing same. The anti-HBsAg antibodies have a higher binding affinity to HBsAg at a neutral pH than at an acidic pH, thereby significantly enhancing virus clearance efficiency and prolonging virus inhibition time. The antibodies and pharmaceutical composition may be used to prevent and/or treat HBV infections or diseases related to HBV infection (such as hepatitis B) for use in neutralizing the virulence of HBV in the body of a subject (such as a human) to reduce a serum level of HBV DNA and/or HBsAg in the body of the subject, or to activate a humoral immune response of a subject (such as a person infected with chronic HBV or a patient who has chronic hepatitis B) against HBV.
Patent AU-2020289485-A1 (AU)
Title: Methods and compositions for treating cancer with collagen binding drug carriers
Inventor: HUBBELL JEFFREY A
IPC: A61K39/395
Filed: 2020-06-03
Abstract: This disclosure relates to tumor-targeted drug carriers that lead to improved anti-tumor efficacy by efficient delivery of a cytotoxic agent to the tumor microenvironment. Aspects of the disclosure relate to a polypeptide comprising an albumin or IgG Fc domain polypeptide operatively linked to a collagen binding domain. Further aspects relate to a composition comprising a polypeptide, nucleic acid, or cell of the disclosure.
Patent AU-2020294171-A1 (AU)
Title: Selectively altering microbiota for immune modulation
Inventor: CLUBE JASPER
IPC: A61K35/17
Filed: 2020-12-21
Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the 
patient. The invention also relates to methods of modulating treatments or therapies in a subject 
organism by altering microbiota of the subject. The invention also relates to cell populations, systems, 
arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective 
targeting of a particular species in a human gut microbiota using guided nucleic acid modification is 
carried out to effect the alteration.  
[FIGURE 12] 
17188619_1 (GHMatters) P110251.AU.2
12/17 
ru 
-o 
0 
I-2 CLcLCLC 
IbL) Co L 
ZZZ 
C< 
LIn
Patent AU-2020294855-A1 (AU)
Title: Homomorphic encryption with applications to private information retrieval
Inventor: GENTRY CRAIG BROADWELL
IPC: H04L9/00
Filed: 2020-06-15
Abstract: A request is received for specific information that can be determined using data in a database on a first computer system. Either at least some of the data is encrypted or the request is encrypted. The first computer system does not have a decryption key to decrypt the encrypted data or request. The first computer system peforms compressible HE operations on the data to determine compressed ciphertext(s) that correspond to the specific information. The operations include using a first uncompressed HE scheme and a second compressed HE scheme. The first HE scheme is used on the data to create other multiple ciphertexts and the second HE scheme is used on the other multiple ciphertexts to pack the other multiple ciphertexts into fewer ciphertexts that are compressed. Both the HE schemes use a same secret key. The first computer system sends a response including compressed ciphertext(s) corresponding to the specific information.
Patent AU-2020295308-A1 (AU)
Title: Agents for cleaving labels from biomolecules in vivo
Inventor: ROSSIN RAFFAELLA
IPC: C07K16/30
Filed: 2020-06-17
Abstract: Disclosed herein are compounds comprising trans-cyclooctene moieties, combinations, and kits that can be used to more quickly remove radionuclides from a subject, preferably a human being. Said compounds, combinations and kits can also be used to increase the tumor-to-blood ratio, or to more rapidly and/or conveniently achieve such an increase, of a label in targeted imaging or targeted radiotherapy in a subject, preferably a human being.